small-cap

One Consumer Discretionary Stock to Sell - InvoCare Limited

Dec 13, 2017 | Team Kalkine
One Consumer Discretionary Stock to Sell - InvoCare Limited

InvoCare Limited (ASX: IVC)


IVC Details

Vulnerable to market weakness: InvoCare is a leading international provider of services related to funeral, cemetery and crematoria, and is a market leader in Australia, New Zealand and Singapore with circa 25% market share of funeral markets. InvoCare, which runs 250 funeral homes and crematoriums, has $508 million in funds under management from people who have signed pre-paid funeral contracts, with about 30% of the funds directly invested in property. With the rising population, the number of deaths are expected to be up gradually and will accelerate post 2022 in view of the life expectancy scenarios, and this might become favourable for the stock thereafter.

In year 2017, the group’s existing banking syndicate’s funding lines were increased from $290 million to $350 million to meet the funding needs. Group’s Protect and Grow Plan requires an incremental capital investment of circa $200 million over four years. During 2017, IVC also sold one of its properties which was held as an investment for a price of $270 million and resulted in profits of approximately of $14 million in 2017.

Trend Analysis of Death Rate (Source: Company Reports)
 
The group has exited US market by closing its funeral operations and its cremation service business. Its objective of improving performance is by managing geographies rather than by brand and by driving its regions through more local managers. In this regard, the group has restructured operations across all regions in Australia and New Zealand. The group has prepared a plan for 2018 for future growth to achieve returns on invested capital consistent with historical levels that is 15% circa.

InvoCare has a market share of about 32% in the Australian funerals and crematorium industry and operates businesses including White Lady Funerals, Simplicity Funerals and Tobin Brothers. InvoCare's net profit for the six months ending June 30, 2017, climbed by 50.1% to $41.7 million, while revenue was up by 1.7% to $218.2 million. Over the long term, the outlook is for continued improvement in operating EBIDTA and a double digit operating EPS growth with the help of Protect and Growth Investment Plan.

Stock Performance: Looking at the trading scenario, there is not much of underlying growth to justify the valuation.In past six months, there is an increase of 17.34% in stock price (as at December 11, 2017), and some level of uncertainty now prevails given the infant nature of price comparison platforms and distribution aggregators in Australia for funeral service businesses. With the lowering of sentiments and underperformance expected in the market in short to medium term with IVC’s vulnerability to the weakness, we give a “Sell” recommendation at current market price of $16.69


IVC Daily Chart (Source: Thomson Reuters)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Past performance is not a reliable indicator of future performance.